Clinical Trials Browser

Phase 3 × trilaciclib × 90 days × Clear all

NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Limited Stage Small Cell Lung Cancer